BridgeBio 药 BBIO
$74.29 +$0.02 (+0.03%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $74.36 +0.09%
开盘$74.21
昨收$74.27
当日区间$73.19 – $75.70
成交量3.16M
市值$14.47B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数18
平均目标价$109.69+47.7% 较现价
- 买入 94%
- 持有 6%
最低 $88.00现价 $74.29均值 $109.69最高 $156.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$87.00至$156.00，平均为$104.58。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 2 Nov 2026 | CCORF | BUY | $108.00 |
| 2 Nov 2026 | Barclays | BUY | $156.00 |
| 30 Oct 2026 | Wells Fargo | BUY | $102.00 |
| 30 Oct 2026 | UBS | BUY | $92.00 |
| 30 Oct 2026 | Piper Sandler | BUY | $120.00 |
| 30 Oct 2026 | BofA Securities | BUY | – |
| 30 Oct 2026 | Morgan Stanley | BUY | $88.00 |
| 30 Oct 2026 | Evercore | BUY | $130.00 |
| 30 Oct 2026 | Citi | HOLD | $91.00 |
| 30 Oct 2026 | RBC Capital | BUY | $100.00 |
| 29 Oct 2026 | TD Cowen | BUY | $100.00 |
| 29 Oct 2026 | Cantor Fitzgerald | BUY | $110.00 |
| 29 Oct 2026 | Wells Fargo | BUY | $102.00 |
| 25 Oct 2026 | Cantor Fitzgerald | BUY | $110.00 |
| 22 Oct 2026 | Morgan Stanley | BUY | $87.00 |
| 21 Oct 2026 | Morgan Stanley | BUY | $87.00 |
| 20 Oct 2026 | Citi | HOLD | $91.00 |
| 19 Oct 2026 | Piper Sandler | BUY | $120.00 |
| 19 Oct 2026 | BofA Securities | BUY | $102.00 |
| 19 Oct 2026 | Citi | HOLD | $91.00 |
暂无评论——快来第一个聊聊 BBIO。